Source: Annual Congress 2010 - Pulmonary infections and sepsis
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
C. Prys-Piccard, B. Williams, V. Cardenas, G. Sharma (Galveston, United States Of America). Outcomes of patients on multiple vasopressor therapy. Eur Respir J 2010; 36: Suppl. 54, 4252

Member's Comments

No comment yet.

Related content which might interest you: Outcomes of Fibrinolytic therapy for acute empyema. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017 Year: 2017 Outcomes of patients with COVID-19 pneumonia treated with CPAP Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Nicotine replacement therapy in ICU patients Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases Year: 2012 Management of recurrent PE in patients on anticoagulant therapy Source: Virtual Congress 2021 – Pulmonary embolism: special situations Year: 2021 CompERA-XL: International, prospective registry for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 The effect of frequent use of hypnotics on HRQOL in patients receiving LTOT and/or long-term NIV Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Outcome of two patients with lymphangioleiomyomatosis without anti-estrogen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 96s Year: 2006 Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Outcome of failed empirical antibiotic therapy on the mortality of elderly patients with hospitalized pneumonia: A propensity score-based analysis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Outcomes in patients requiring CPAP for COVID-19 infection in non-ITU settings Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Assessment and therapy for COPD patients in real-life primary care Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Outcomes of drug-resistant TB cases undergoing bedaquiline (BQ)-treatment and adjunctive surgery Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Outcomes of pulmonary rehabilitation according maintenance treatment in real life COPD patients Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020